Skip to main content

JPMORGAN CHASE & CO

Position in CELC — Celcuity Inc.

CIK 19617 NEW YORK, NY

Position in CELC

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$6,148,263
+$1,055,640 QoQ
Shares Held
53,866
+5.5% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 50.09467938959641.ToString("F0")% Shared 0.ToString("F0")% None 49.90532061040359.ToString("F0")%

Common Shares in CELC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,578,690,346 across 405 Biotechnology names. CELC ranks #90 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CELC

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,148,263 53,866
2025-12-31 $5,092,623 51,059
2025-09-30 $2,571,022 52,045
2025-06-30 $183,041 13,711
2025-03-31 $157,906 15,619
2024-12-31 $192,200 14,683
2024-09-30 $179,022 12,007
2024-06-30 $386,877 23,619
2024-03-31 $1,276,862 59,114
2023-12-31 $248,359 17,046
2023-09-30 $108,217 11,840
2023-06-30 $146,703 13,361
2023-03-31 $10,065 982
2022-12-31 $69,629 4,970
2022-03-31 $42,402 4,535
2021-12-31 $48,907 3,708
2021-09-30 $133,074 7,393
2021-06-30 $224,928 9,372
2021-03-31 $57 4
2020-12-31 $36 4
2020-09-30 $40 7
2020-06-30 $2,729 394
2020-03-31 $63,687 9,798